| Study Details | To Evaluate the Efficacy and Safety of MK-0616 in Adults With Heterozygous Familial Hypercholesterolemia |
| Protocol Number | MK-0616-017-00 |
| Phase | III |
| Therapeutic Area | Endocrinology |
| Subject Types | With Medical Condition |
| Indication | Heterozygous Familial Hypercholesterolemia |
| Principal Investigator | Dr Eng Pei Chia |
| Investigator Product / Device | MK-0616 |
| Sponsor | Merck Sharp & Dohme LLC |
